Newsletter: Vol. 6, No. 2, September 2022

In this issue, read about published research on the safety, acceptability, and feasibility of a medication abortion telemedicine model in Mexico, a comment on the limitations of randomized trials of medication abortion as well as details of a new study to further the evidence-base for a later first trimester medication abortion regimen and early findings from a pilot study exploring an ‘asynchronous’ approach to medication abortion care. Find out also about our speaking engagements and recent publications.

Read the full Newsletter.